Gland Pharma Reports Jump in Second Quarter Profit
India's Gland Pharma posted a larger-than-expected 58 percent increase in second-quarter net profit, driven by strong sales growth in key United States and European markets.
Xurve View
Insights:
Xurve View
GLAND PHARMA LTD posted a 58.3% jump in second-quarter profit on Friday, beating consensus estimates on strong sales across United States and European markets. Consolidated net profit rose to 2.91 billion rupees ($30.9 million) from 1.84 billion rupees a year earlier. The Hyderabad-based drugmaker surpassed LSEG consensus estimates of 2.75 billion rupees.
